What is the recommended antibiotic treatment for an acute bacterial infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Acute Bacterial Infections

For acute bacterial infections, initiate short-course antibiotic therapy (3-5 days) with pathogen-specific agents, prioritizing amoxicillin for respiratory infections, nitrofurantoin or TMP-SMZ for uncomplicated UTIs, and amoxicillin-clavulanate for skin infections, with treatment duration guided by clinical response rather than arbitrary extended courses. 1

Treatment Duration: The Shift to Shorter Courses

The most critical evidence-based change in antibiotic management is the move away from prolonged courses:

  • For community-acquired pneumonia (CAP): A 5-day course is sufficient when patients achieve clinical stability (no fever for 48 hours), with 70% of patients successfully completing treatment at this duration without increased failure rates 1

  • For uncomplicated cystitis in women: Use nitrofurantoin for 5 days, TMP-SMZ for 3 days, or fosfomycin as a single dose 1

  • For uncomplicated pyelonephritis: Fluoroquinolones for 5-7 days (not 10 days) or TMP-SMZ for 14 days based on susceptibility 1

  • For cellulitis (including COPD patients): A 5-day course is recommended, with extension only if infection has not improved 2

  • For complicated intra-abdominal infections: After adequate source control, 3-5 days of antibiotics produces similar outcomes to longer courses 1

First-Line Antibiotic Selection by Infection Type

Respiratory Tract Infections

Acute Bacterial Sinusitis:

  • Delay antibiotics until symptoms persist ≥10 days or worsen after 5-7 days to distinguish bacterial from viral etiology 1
  • First-line: Amoxicillin 3g/day for adults 1 or amoxicillin-clavulanate for children 1
  • Duration: 10-14 days for sinusitis 1, though shorter courses of newer agents show similar efficacy 1

Community-Acquired Pneumonia:

  • Adults without risk factors: Amoxicillin 3g/day orally for suspected pneumococcal infection (especially >40 years) 1
  • Adults <40 years without underlying disease: Macrolides for atypical bacterial pneumonia 1
  • Children: Amoxicillin 80-100 mg/kg/day in three divided doses for <30 kg 1
  • Duration: 10 days for pneumococcal pneumonia, 14 days for atypical pneumonia 1

Acute Bronchitis:

  • Do not prescribe antibiotics for acute bronchitis in healthy adults—it is predominantly viral and antibiotics provide no benefit over placebo 1

Pediatric Infections

Acute Bacterial Sinusitis in Children:

  • Severe presentation (fever ≥39°C + purulent discharge ≥3 days) or worsening symptoms: Immediate antibiotic therapy 1
  • Persistent symptoms (≥10 days): Either antibiotic therapy OR additional 3-day observation period 1
  • First-line: Amoxicillin with or without clavulanate 1

Acute Otitis Media:

  • Azithromycin: 30 mg/kg as single dose, OR 10 mg/kg daily for 3 days, OR 10 mg/kg day 1 then 5 mg/kg days 2-5 3
  • Number needed to treat is 3-5 for persistent symptoms 1

Urinary Tract Infections

Uncomplicated Cystitis (Women):

  • Nitrofurantoin 5 days, TMP-SMZ 3 days, or fosfomycin single dose 1
  • Avoid fluoroquinolones empirically due to adverse effect profile; reserve for resistant organisms 1

Uncomplicated Pyelonephritis:

  • Fluoroquinolones 5-7 days (not 10 days) OR TMP-SMZ 14 days based on susceptibility 1
  • Clinical cure rates exceed 93% with 5-day fluoroquinolone courses 1

Skin and Soft Tissue Infections

Cellulitis:

  • 5-day course with extension only if no improvement 2
  • Mild-moderate: Clindamycin 300-450 mg orally four times daily for 5 days (especially for penicillin allergies) 2
  • Alternative: Amoxicillin-clavulanate for dual coverage of respiratory and skin pathogens 2
  • Add MRSA coverage (TMP-SMZ or clindamycin) only with specific risk factors 2
  • Adjunctive measure: Elevate affected area to promote drainage 2

Critical Assessment Points

Evaluate treatment response at 48-72 hours:

  • For sinusitis: Symptoms should decrease within this timeframe; do not change antibiotics before 72 hours unless clinical worsening 1
  • For cellulitis: Assess within 3-4 days; if no improvement by 5 days, extend therapy and reassess for alternative causes rather than defaulting to longer treatment 2
  • For pneumonia: Clinical stability criteria include no fever for 48 hours 1

When to extend beyond short-course therapy:

  • Patients with ongoing signs of infection beyond 5-7 days warrant diagnostic investigation for uncontrolled source or treatment failure 1
  • Each additional day of antibiotics carries 5% increased risk of adverse events without added benefit 1

Common Pitfalls to Avoid

Do not treat viral infections with antibiotics:

  • Acute bronchitis in healthy adults is viral; antibiotics provide no benefit 1
  • Purulent sputum during acute bronchitis does not indicate bacterial superinfection 1

Do not use antibiotics for dental infections without surgical intervention:

  • For acute dental abscesses, treatment is surgical only (root canal or extraction) 1
  • For acute dentoalveolar abscesses, perform incision and drainage first, then amoxicillin for 5 days 1

Avoid unnecessary broad-spectrum coverage:

  • Start with narrow-spectrum agents and de-escalate once organism identified 4
  • Combination therapy is not more effective than monotherapy in most ICU trials 4

Do not prescribe antibiotics for uncomplicated acute bacterial sinusitis before 10 days:

  • Bacterial sinusitis is uncommon with symptoms <10 days duration 1
  • This approach reduces unnecessary antibiotic use in viral infections 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment for Cellulitis in Patients with COPD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Antibiotics in the critically ill].

Medicinski pregled, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.